Efroni S - Search Results

1

Predicting and affecting response to cancer therapy based on pathway-level biomarkers.

Ben-Hamo R, Jacob Berger A, Gavert N, Miller M, Pines G, Oren R, Pikarsky E, Benes CH, Neuman T, Zwang Y, Efroni S, Getz G, Straussman R. Ben-Hamo R, et al. Among authors: efroni s. Nat Commun. 2020 Jul 3;11(1):3296. doi: 10.1038/s41467-020-17090-y. Nat Commun. 2020. PMID: 32620799 Free PMC article.

2

Detecting cancer gene networks characterized by recurrent genomic alterations in a population.

Efroni S, Ben-Hamo R, Edmonson M, Greenblum S, Schaefer CF, Buetow KH. Efroni S, et al. PLoS One. 2011 Jan 4;6(1):e14437. doi: 10.1371/journal.pone.0014437. PLoS One. 2011. PMID: 21283511 Free PMC article.

3

The whole-organism heavy chain B cell repertoire from Zebrafish self-organizes into distinct network features.

Ben-Hamo R, Efroni S. Ben-Hamo R, et al. Among authors: efroni s. BMC Syst Biol. 2011 Feb 10;5:27. doi: 10.1186/1752-0509-5-27. BMC Syst Biol. 2011. PMID: 21310065 Free PMC article.

4

Rep-Seq: uncovering the immunological repertoire through next-generation sequencing.

Benichou J, Ben-Hamo R, Louzoun Y, Efroni S. Benichou J, et al. Among authors: efroni s. Immunology. 2012 Mar;135(3):183-91. doi: 10.1111/j.1365-2567.2011.03527.x. Immunology. 2012. PMID: 22043864 Free PMC article. Review.

5

Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

Ben-Hamo R, Efroni S. Ben-Hamo R, et al. Among authors: efroni s. Genome Med. 2011 Nov 28;3(11):77. doi: 10.1186/gm293. Genome Med. 2011. PMID: 22122801 Free PMC article.

6

Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.

Ben-Hamo R, Efroni S. Ben-Hamo R, et al. Among authors: efroni s. BMC Syst Biol. 2012 Jan 11;6:3. doi: 10.1186/1752-0509-6-3. BMC Syst Biol. 2012. PMID: 22236809 Free PMC article.

7

RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.

Feldstein O, Ben-Hamo R, Bashari D, Efroni S, Ginsberg D. Feldstein O, et al. Among authors: efroni s. Mol Cancer Res. 2012 Sep;10(9):1169-77. doi: 10.1158/1541-7786.MCR-12-0331. Epub 2012 Jul 13. Mol Cancer Res. 2012. PMID: 22798430

8

Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

Ben-Hamo R, Efroni S. Ben-Hamo R, et al. Among authors: efroni s. Genome Med. 2012 Nov 29;4(11):87. doi: 10.1186/gm388. eCollection 2012. Genome Med. 2012. PMID: 23194430 Free PMC article. No abstract available.

9

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ. Mascanfroni ID, et al. Among authors: efroni s. Nat Immunol. 2013 Oct;14(10):1054-63. doi: 10.1038/ni.2695. Epub 2013 Sep 1. Nat Immunol. 2013. PMID: 23995234 Free PMC article.

10

MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms.

Ben-Hamo R, Efroni S. Ben-Hamo R, et al. Among authors: efroni s. PLoS Comput Biol. 2013;9(11):e1003351. doi: 10.1371/journal.pcbi.1003351. Epub 2013 Nov 21. PLoS Comput Biol. 2013. PMID: 24278004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters